Home › Funds › Bridgewater Associates › VRTX
Bridgewater Associates position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)10.87K sh
Reported value held$5.40M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 15.12K | $2.74M | New |
| Q4 2021 | 12.42K | $2.73M | Reduce |
| Q1 2022 | 30.15K | $7.87M | Add |
| Q2 2022 | 217.15K | $61.19M | Add |
| Q3 2022 | 163.99K | $47.48M | Reduce |
| Q4 2022 | 100.82K | $29.11M | Reduce |
| Q1 2023 | 204.28K | $64.36M | Add |
| Q2 2023 | 176.31K | $62.05M | Reduce |
| Q3 2023 | 158.35K | $55.06M | Reduce |
| Q4 2023 | 132.35K | $53.85M | Reduce |
| Q1 2024 | 134.69K | $56.30M | Add |
| Q2 2024 | 33.23K | $15.58M | Reduce |
| Q3 2024 | 3.45K | $1.61M | Reduce |
| Q4 2024 | 710 | $285.92K | Reduce |
| Q2 2025 | 34.39K | $15.31M | New |
| Q3 2025 | 38.32K | $15.01M | Add |
| Q4 2025 | 27.49K | $12.46M | Reduce |
| Q1 2026 | 13.36K | $5.96M | Reduce |
| Q2 2026 | 10.87K | $5.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026